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Ischemia in the heart impairs function of the cardiac pacemaker, the sinoatrial node (SAN).
However, the ionic mechanisms underlying the ischemia-induced dysfunction of the SAN remain
elusive. In order to investigate the ionic mechanisms by which ischemia causes SAN dysfunction,
action potential models of rabbit SAN and atrial cells were modified to incorporate extant experi-
mental data of ischemia-induced changes to membrane ion channels and intracellular ion homeo-
stasis. The cell models were incorporated into an anatomically detailed 2D model of the intact
SAN-atrium. Using the multi-scale models, the functional impact of ischemia-induced electrical
alterations on cardiac pacemaking action potentials (APs) and their conduction was investigated.
The effects of vagal tone activity on the regulation of cardiac pacemaker activity in control and
ischemic conditions were also investigated. The simulation results showed that at the cellular
level ischemia slowed the SAN pacemaking rate, which was mainly attributable to the altered
Naþ-Ca2þ exchange current and the ATP-sensitive potassium current. In the 2D SAN-atrium tis-
sue model, ischemia slowed down both the pacemaking rate and the conduction velocity of APs
into the surrounding atrial tissue. Simulated vagal nerve activity, including the actions of acetyl-
choline in the model, amplified the effects of ischemia, leading to possible SAN arrest and/or con-
duction exit block, which are major features of the sick sinus syndrome. In conclusion, this study
provides novel insights into understanding the mechanisms by which ischemia alters SAN func-
tion, identifying specific conductances as contributors to bradycardia and conduction block.
VC 2017 Author(s). All article content, except where otherwise noted, is licensed under a Creative
Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
[http://dx.doi.org/10.1063/1.5002664]
Sinus bradycardia, a phenotype of sick sinus syndrome
(SSS), may be caused by sinoatrial node (SAN) ischemia.
Recent experimental studies have focused on characteriz-
ing ischemia-induced changes to membrane ion channels
of nodal cells. However, it is still unclear how such
changes at the cellular ion channel level may cause sinus
bradycardia, compromising the ability of the SAN to
pace and drive the surrounding atrium, given that the
cardiac pacemaker is an integrative and complex nonlin-
ear system. In this study, we address these issues with
multi-scale models of the SAN, from single cell to 2D
SAN-atrium tissue levels. The functional impact of
ischemia-induced electrophysiological changes on cardiac
pacemaking action potentials and their conduction was
investigated. Effects of vagal tone activity on the regula-
tion of cardiac pacemaker activity in control and ische-
mic conditions were also studied. The results provide new
insights into understanding the mechanism by which
ischemia causes cardiac pacemaker dysfunction, and why
SSS patients have significantly lower heart rates (even
sudden death) at night when the vagal tone is high.
I. INTRODUCTION
The sinoatrial node (SAN), the pacemaker of the mam-
malian heart, possesses intrinsic automaticity. Dysfunction
of the SAN may lead to abnormal cardiac rhythms, mani-
fested by intermittent sinus bradycardia, sinus arrest, sinus
pause, slow SAN-atrium conduction, sinus exit block or
alternating bradycardia and atrial tachycardia.1,2
SAN dysfunction may arise from a variety of conditions,
such as ageing,3 gene mutations,4,5 and cardiac ischemia.6 In
the latter case, the sinus node artery, which carries the main
blood supply to the SAN, may suffer from hypoperfusion,
causing ischemia that impairs SAN function. Experimental
studies have shown that occlusion of the sinus node artery
produces various dysrhythmias, including sinus slowing and
a)Author to whom correspondence should be addressed: henggui.zhang@
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sinoatrial block.7–9 With decreasing sinus rhythm, cardiac out-
put and blood pressure decreases, and in some extreme cases,
sinus arrest may occur causing sudden death.10 Although
ischemia-induced SAN dysfunction can be fatal, the exact
underlying ionic mechanisms remain elusive.
Prior studies have been carried out to characterize the
effects of ischemia on the electrophysiological properties of
mammalian atrial and ventricular myocytes (e.g., Refs.
11–13). It has been found that ischemia is associated with
acidosis, hyperkalemia and hypoxia, each of which produces
alterations to the electrophysiological properties of cardiac
cell and tissues, including changes to ion channel properties
and intercellular electrical coupling.12,14 These changes may
be responsible for the genesis of cardiac arrhythmias during
ischemia.14,15 However, there is little experimental informa-
tion on the effects of ischemia on the electrophysiological
properties of SAN due to its complicated and heterogeneous
anatomy. Experimental evidence suggests that ischemia can
also modulate ion channel function in SAN cells, producing
an increased L-type calcium channel current (ICaL)
16 and
hyperpolarization activated inward current (If), but decreased
T-type calcium channel current (ICaT), rapid and slow com-
ponents of the rectifier potassium channel currents (IKr and
IKs), and Na
þ-Ca2þ exchanger activity (INaCa).
6,16,17
However, it is still unclear if the changes identified at the
cellular ion channel level are sufficient to account for the
ischemia-induced sinus bradycardia, a nonlinear behaviour
arising from the interactions of millions of SAN cells. The
relative roles of ischemia-induced changes to altered particu-
lar ion channel currents in compromising SAN pacemaking
activity and the ability of the SAN to drive the surrounding
atrial muscle are yet to be elucidated. Acetylcholine (ACh),
the neurotransmitter released by the vagal nerves is known
to slow down the pacemaking rate (PR).18–20 Measurements
from anaesthetized dogs have demonstrated that vagal action
on the heart rate can be potentiated during SAN ischemia.21
However, whether and how the vagal activity compromises
the SAN pacemaking activity during ischemia has not yet
been elucidated.
Computational models of the heart have provided pow-
erful tools to study the functional effects of gene muta-
tions,4,5 heart failure,22,23and ageing24,25on cardiac
pacemaker activities. Being constructed from, and validated
against experimental data, they provide a means for quantita-
tively predicting the functional roles of altered molecular
dynamics and ionic channels in a systematic way that is diffi-
cult to achieve in an experimental setting.4,26,27 In previous
computational work, Butters et al. showed that SCN5A gene
mutations are causally linked to the sick sinus syndrome.4
Modelling has also been used to investigate the mechanisms
by which ankyrin-B defects increase susceptibility to SAN
dysfunction and atrial fibrillation and the functional impact
of heart failure on SAN.28,29 In this study, we developed
multi-scale (cell and tissue) models of the rabbit SAN-atrium
in control and ischemic conditions. Using these models we
investigated the functional impact of ischemia on the initia-
tion and conduction of SAN action potentials and their con-
duction into the atrium.
II. METHODS
A. Mathematical models of single cell and
2D SAN-atrium tissue
The consequences of ischemia-induced electrophysio-
logical alterations for SAN cells were investigated by using:
(1) electrophysiologically detailed central and peripheral
SAN cell models;30 (2) a 2D anatomical model of the intact
SAN-atrium tissue, incorporating accurate single cell models
of the SAN30 and the right atrium (RA),31 together with the
reconstructed tissue geometry.32 These single cell models
have been validated in prior studies.30,31 In numerical simu-
lations, the time step was chosen to be 0.01ms at the cellular
level. In the 2D intact SAN-atrium model, we used the same
time step with a space step of 0.04mm which gave accurate
numerical solutions.
B. 2D tissue slice model
The 2D anatomical model of the intact SAN-atrium
tissue used in this study was reconstructed from histologi-
cal and immunohistochemistry imaging data.32 In brief,
the model considered distinct regions of the SAN-atrium,
with consideration of the intrinsic electrical heterogeneity
in the atria and central and peripheral SAN cells.32,33 The
anatomical geometry of the model was based on the recon-
structed endocardial surface of the 3D SAN-atrium tis-
sue32 (see Fig. S1 in the supplementary material), which
was discretized by a high spatial resolution of 0.04mm to
form a regular Cartesian grid of 385 250 nodes. Each
node had a flag variable to identify the cell type (the SAN
central, peripheral and RA cell), based on immunohisto-
chemistry mapping data.32 The central and peripheral SAN
cells were modelled by the Zhang et al. equations,30 and
atrial cells of the RA were modelled by the Aslanidi et al.
equations.31
Similar to our prior studies,4,34 in the 2D intact SAN-
atrial tissue model we incorporated local variations of cel-
lular electrophysiology as observed experimentally; these
included regional differences of cell membrane capacitance
(Cm), the diffusion coefficient (D; as a determinant of con-
duction velocity) and cellular electrophysiological proper-
ties32 (see Fig. S2 in the supplementary material). Spatial
distributions of current densities were correlated with the
cell membrane capacitance, Cm, which increases gradually
from the centre to the periphery of the SAN.30,34 The gradi-
ent distribution of D was introduced according to Zhang
et al.34 In order to model the effects of ACh on SAN cells,
the ACh-activated Kþ current, IK,ACh was incorporated,
ICaL was partially inhibited, and the activation curve of If
was shifted toward more negative potentials. Detailed
equations and parameters used in the model have been
given in the work of Butters et al.4 The 2D anatomical
model of the intact SAN-atrium was validated by its ability
to reproduce the correct sequence of action potential (AP)
initiation and conduction through the rabbit intact SAN-
atrium, as found experimentally3,35 (see Fig. S1in the sup-
plementary material).
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C. Ischemic SAN model
1. Changes to ion channel currents
In order to model effects of ischemia on the SAN, the con-
ductances of some of the main ionic channel currents responsi-
ble for cellular depolarization and repolarization were adjusted,
based on experimental data on the effects of ischemia on the
rabbit SAN (see Table I).6,16 These changes include an
increased L-type calcium channel conductance (gCaL; increased
by 110%),16 a decreased T-type calcium channel conductance
(gCaT; decreased by 36.8%),
6 decreased rapid- and slow-
delayed rectifier potassium channel conductance (gKr and gKs;
decreased by 16% and 26% respectively)6 and decreased Naþ/
Ca2þ exchanger (gNaCa; decreased by 42%)
6 current. It was
shown in a previous experimental study that in “ischemic”
Tyrode’s solution the funny current (If) of SAN cells increased
by 15.3% at 60mV.16 As sodium channel current (INa) is pre-
sent in the peripheral SAN cells and does contribute to the
pacemaking and driving ability of the SAN,30,36 an ischemia-
induced reduction in the channel conductance (gNa; decreased
by 25%)14,37 as observed in ventricular cells was also consid-
ered in simulations (see Table I, the right column).
2. Hyperkalemia
For simulating hyperkalemia during ischemia, the extra-
cellular potassium concentration ([Kþ]o) was elevated by
50% as observed experimentally.38,39
3. ATP-sensitive channel current (IKATP) due to hypoxia
Previous experimental studies suggest that the metabolic
depletion-activated K-ATP channel current (IKATP) may play
an important role in the pathogenesis of SAN dysfunction
during cardiac ischemia.40,41 It has been shown that IKATP
channel openers regulate the maximum diastolic potential
(MDP) and pacemaking rates of rabbit SAN cells.42,43
Similar functional effects of IKATP on regulation of cardiac
pacemaking APs have also been observed in mice during
hypoxia.41,44 Therefore, in simulations we incorporated the
IKATP formulation developed by Ferrero et al.
45 Details of
the IKATP formulation can be found in the supplementary
material.
4. Changes of ionic homeostasis and energy
metabolism
The homeostasis of Hþ in rabbit SAN cells is main-
tained by the Naþ/Hþ exchanger,46 which may lead to an
increased intracellular Naþ concentration ([Naþ]i) during
ischemia. In addition, some other studies from ventricular
cells have found that the intracellular free Naþ concentration
is increased due to the hypoxia-induced depletion of the cel-
lular ATP content.47,48 However, these experimental data are
absent for rabbit SAN cells. In order to consider all possible
actions of ischemia in simulations, some data from ventricu-
lar ischemia experiments were also considered, including
changes in intracellular ATP (ATPi), the extracellular ADP
(ADPi), and the intracellular Na
þ concentration. For details,
please see Table I.
III. RESULTS
A. SAN effects of ischemia at the single cell level
The effects of ischemia-induced changes on cellular ion
channels and ion homeostasis (see Table I) on spontaneous
action potentials of SAN cells were first investigated. The
results are shown in Fig. 1, in which simulated action
TABLE I. Ischemia-induced electrophysiological changes in rabbit SAN cells. All the experimental data on ischemia-induced ion channel remodeling were
from rabbit SAN cells with 5 or 7min ischemia. Other experimental data were based on rabbit ventricular cells with mild ischemia condition.
Changed factors Percentage of change (normalized to control condition) Changed factors Percentage of change (normalized to control condition)
gCaL "110% (Ref. 16) gNa #25% (Refs. 14 and 37)
gCaT #36.8% (Ref. 6) [Naþ]i "66% (Refs. 49 and 50)
gKr #16% (Ref. 6) ATPi (mmol/l) 4.6 (Refs. 38 and 45)
gKs #26% (Ref. 6) ADPi (lmol/l) 99 (Refs. 38 and 45)
kNaCa #42% (Ref. 6)
gf (gf,Na and gf,K) "15.3% (Ref. 16) [Kþ]o "50% (Refs. 38 and 39)
FIG. 1. Effects of ischemia on SAN action potentials. (a) Simulated action
potentials in control and ischemic conditions for central (ai) and peripheral
(aii) cells. (b) Effects of ischemia on the pacemaking rate (PR) of central
(bi) and peripheral (bii) cells. Simulation data were compared with the
experimental data of Du and Nathan.6
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potentials in the ischemic condition are superimposed on
those in the control condition [Fig. 1(a)]. Ischemia increased
the overshoot of the APs, which corresponded to the experi-
mental observation of Du and Nathan;6 prolonged the action
potential duration, and hyperpolarized the MDP in the cen-
tral cell model, but depolarized the MDP in the peripheral
cell model. In both cell models, the phase-4 depolarisation
process was slowed down, leading an increased pacemaking
cycle length (PCL; the time interval between two successive
pacemaking APs); consequently there was a deceleration of
the pacemaking rate. Ischemia increased PCL by about
41.2% in the central cell model, which was close to the
experimental data of Du and Nathan6 (PCL increased by
43%). A 23.5% increase of PCL in the peripheral cell model
was observed, which was somewhat smaller than experimen-
tal data6 [as shown in Fig. 1(b)]. Therefore, our simulation
results show that the ischemia-induced changes in ion chan-
nel currents, ionic concentrations, and the activation of IKATP
are sufficient to account for the bradycardia observed in
ischemic rabbit SAN cells. The more depolarised MDP in
the peripheral cell model with ischemia matched the experi-
mental observation of Du and Nathan.6 The modest hyperpo-
larization of MDP in the central cell model with ischemia
differed from the experimental data of Du and Nathan.6 In
the study of Du and Nathan,6 SAN cells were isolated from a
rectangular piece of nodal tissue with a size of (1.0–1.5)
 (3.0–3.5) mm located at about 0.5–1.0mm from the crista
terminalis (CT), with cell capacitance ranging from 20 pF to
62 pF; this wide range of cell sizes suggests that the isolated
cell population may have contained both central (small
capacitance) and peripheral (large capacitance) cells. In sim-
ulations, our cell models considered the intrinsic regional
heterogeneity of the SAN,31 which assumed a cell capaci-
tance of 20 pF for the central cell and 65 pF for the peripheral
cell models. This may account for the discrepancy between
the simulation and the experimental data of Du and Nathan
for the modest hyperpolarized membrane potential.
The roles of each individual ischemia-induced cellular
change in alterations to SAN cell APs were investigated by
using either an “inclusive” method or an “exclusive”
method. With the inclusive method, each individual ischemic
action was considered alone in simulations. With the exclu-
sive method, the individual ischemic action of interest was
excluded from the integral action of ischemia. Figure 2
shows the results obtained from the inclusive method. It
illustrates that in both the central and peripheral cell models
the ischemia-induced increase of ICaL played a primary role
in prolonging the action potential duration (APD) (by 20.0%
in the central cell [Fig. 2(ai); and by 26.9% in the peripheral
cell model], whilst the elevation of [Naþ]i abbreviated APD
(by 24.0% in the central cell model and by 2.3% in the
peripheral cell model). Other ischemic actions on ionic chan-
nel currents, ion concentration or the activation of IKATP had
non-marked effects with respect to APD prolongation.
In the central cell model, the ischemia-induced decreases
of ICaT and INaCa, the activation of IKATP and the increase of
[Naþ]i contributed markedly to the slowing down of the pace-
making APs, producing an increased cycle length (PCL) [Fig.
2(bi)] (by 6.1%, 3.9%, 11.1% and 84.8% respectively). The
increased If reduced PCL (by 0.86%) in the central cell
model. Note that in the central cell model, the increase in
[Naþ]i during SAN ischemia produced the largest increase in
PCL. For the peripheral cell model, results were different
from those in the central cell model due to their intrinsic dif-
ferences in ion channel properties.21,25 Our results suggested
that the altered ICaT, IKr, IKs, and INaCa had almost no effect
on PCL in the peripheral cell model [Fig. 2(bii)], while
the ischemia-induced decrease of INa, activation of IKATP,
increases of [Naþ]i and ICaL caused an increase of PCL by
3.9%, 1.4%, 7.2%, and 17.2%, respectively. Note that in the
peripheral cell model the increase of ICaL contributed the
most to the PCL increase, which resulted from an increase of
the APD as shown in Fig. 2(aii). Simulations from the exclu-
sive method showed similar results with respect to the influ-
ence of each individual ischemic action on SAN APs to the
inclusive method, as shown in Figs. S3, S4, and S5 in the sup-
plementary material.
Further simulations were performed to elucidate the mech-
anisms by which the [Naþ]i increase ([Na
þ]i¼ 13.28mM) dur-
ing ischemia slowed down pacemaking. The results are
shown in Fig. 3 for central (left panels) and peripheral (right
panels) cells in control and [Naþ]i. In both cell models, it was
found that an increased [Naþ]i resulted in an increased PCL
and more hyperpolarized MDP [Figs. 3(ai) and 3(aii)]. It
reduced the AP amplitude and duration in the center model,
but not in the periphery model. These changes in AP profiles
were associated with an increased INaK [Figs. 3(ci) and
3(cii)], a reversed operating mode of INaCa (i.e., increased the
outward component) [Figs. 3(di) and 3(dii)], all of which con-
tributed to the slowing down of the pacemaking rate, though
there was an increased If [Fig. 3(ei)] due to a more hyperpo-
larized MDP. In simulation, an increased [Naþ]i had more a
prominent effect in the central cell model than in the periph-
ery cell model, which was attributable to the differences in
ion channel properties of the two cell types.21,25
FIG. 2. Role of each individual ischemic action on APD (a) and pacemaking
cycle length (b) for central (ai) and (bi) and peripheral (aii) and (bii) cells.
APD was measured at a membrane potential of 30mV.
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B. Effects of ACh on SAN cell activity
ACh has been established to slow down pacemaking by
increasing the PCL in both central and peripheral SAN cells,
with a larger effect on the central cells.38,45 It is not known
whether the negative chronotropic action of ischemia is aug-
mented by ACh. To address this question, further simulations
were performed in which effects of ACh on SAN APs in
control and ischemic conditions were studied. The results
are shown in Fig. 4. In the control condition, the simulated
effects of a “physiological” ACh concentration ([ACh]
¼ 3.0 108mol/l) 18–20 resulted in the PCL increasing from
352.5ms to 403.2ms (by 14.4%) for the central cell [Fig.
4(ai)], and from 181.4ms to 192.7ms (by 6.2%) for the
peripheral cell [Fig. 4(aii)]. The negative chronotropic effect
of ACh was due to the integrated actions of activation of
IK,ACh [Fig. 4(b)], changes in ICa,L [Fig. 4(c)] and If [Fig.
4(d)]. In the ischemic condition, application of ACh
increased the PCL of the central and peripheral cell models
by 72.9% and 30.2% respectively compared to control; these
changes were markedly greater than those under ischemic
condition (i.e., PCLs were increased by 41.2% and 23.5%
respectively as compared to control condition). As such, the
negative chronotropic effects of ACh were amplified by
ischemia in both the centre and the peripheral cell models.
The dose-dependent effects of ACh on APs in control
and ischemic conditions were also considered. Figure 5
presents the results obtained from the central and peripheral
cell models for various “physiological” [ACh].18–20 It shows
that an increase of ACh concentration resulted in an increase
in the PCL of both cell types. The negative chronotropic
effect of all ACh concentrations was amplified by ischemia.
At an ACh concentration of 8.0 108mol/l, central SAN
cells still exhibited pacemaking (though with a prolonged
PCL) in the control condition, but became quiescent in the
ischemic condition [Fig. 5(bi)]. Similar results were seen in
the ischemic peripheral cell at an ACh concentration of
4.0 107mol/l [Fig. 5(cii)]. Figure 5(d) summarizes the
simulated dose-dependent effect of ACh on PCLs in control
and ischemic conditions. It shows that ischemia shifted the
dose-dependence of the PCL leftwards, indicating a more
suppressive effect of ACh on SAN cells during ischemia.
FIG. 3. Effects of intracellular sodium overload on spontaneous action
potentials and underlying ion currents for central [left panels, (ai)–(ei)] and
peripheral [right panels, (aii)–(eii)] SAN cells. (a) action potentials. (b) INa.
(c) INaK. (d) INaCa. (e) If.
FIG. 4. Effects of ACh under control and ischemic conditions. Simulated
action potentials and underlying currents of the central (ai)–(di) and peripheral
(aii)–(dii) SAN cells. [ACh]¼ 3.0 108mol/l. (a) APs; (b) IK,ACh; (c) ICa,L;
(d) If; (e) Pacemaking cycle length in central (ei) and peripheral (eii) cells.
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C. Two-dimensional tissue effects
Due to the electrotonic interaction between the SAN and
atrium, the functional impact of ischemia seen at the isolated
single-cell level may be different to that seen in the intact
SAN-atrium tissue level. Thus, in addition to single cell simu-
lations, multicellular tissue models must be used to evaluate
the functional consequences of ischemia and ACh in the set-
ting of ischemia. Therefore, simulations of activity from intact
SAN-atrium tissue under control and ischemia conditions
were conducted, the results of which are shown in Fig. 6.
Figure 6(ai) shows the snapshots of the initiation and
conduction pattern of pacemaking APs in the 2D SAN-
atrium model under control condition at different timings.
The AP was first initiated in the centre of the SAN. Once ini-
tiated, the AP propagated preferentially from the centre
towards the periphery of the SAN, and then to the crista ter-
minalis (CT) before entering the atrium in the direction
towards the right atrium. However, in the direction towards
the atrial septum, the AP conduction was blocked in the con-
duction block zone, which was encircled by excitation waves
from the superior and inferior tissues surrounding the zone.
The simulated activation and AP conduction pattern in the
2D model matches prior experimental data from the rabbit
heart.31
Figure 6(aii) plots the spatial (running vertically) and
temporal (running horizontally) profiles of APs [recorded
from representative cells along the black line across the
SAN-atrium model as shown in Fig. 6(ai)] for three consecu-
tive cycles, demonstrating a stable excitation and conduction
pattern in the intact SAN-atrium model. The measured PCL
was about 367ms, which is close to experimental data
obtained from multicellular tissue recordings of the intact
SAN-atrium of the rabbit heart.31 Note that the measured
PCL at the tissue level was greater than that of isolated cen-
tral SAN cells, which controlled the pacemaking rhythm of
the SAN. This is due to the electrotonic interaction between
the SAN and the atrium,31 which depressed the pacemaking
APs of SAN cells as observed experimentally in previous
studies.31,51
SAN ischemia [Fig. 6(bii)] or application of ACh
(1.0 106mol/l) [Fig. 6(cii)] in the 2D model did not alter
AP conduction patterns (the relative snapshots of the initia-
tion and conduction pattern of the pacemaking action poten-
tials in the 2D tissue shown in Figs. 6(bi) and 6(ci) but
shifted the leading pacemaking sites towards the periphery
by 0.12mm in both conditions. An ACh-induced shift in the
leading pacemaker site has been observed experimentally by
optical mapping.52 In simulations, SAN ischemia and ACh
also slowed down pacemaking rate, resulting in a PCL of
396 and 560ms, respectively. It is of interest that AP con-
duction was also slowed, as demonstrated by the slower
spread of the excitation wavefront in the tissue, as compared
to control tissue shown in Fig. 6(ai). In the normal tissue, the
excitation wavefront spread over the 2D tissue model by
about 80ms, which increased to 90 and 120ms in SAN
ischemia and ACh conditions, respectively.
Combined actions of ACh (1.0 106mol/l) and ische-
mia amplified the negative chronotropic effects of each inter-
vention. The results are shown in Fig. 6(di) for the activation
pattern and 6(dii) for the space-time plots of APs from the
representative cells in the tissue. With an integrated action of
both ACh and SAN ischemia, SAN pacemaking activity was
further slowed, with a measured PCL of 593ms. It is also
notable that the original leading pacemaking site was shifted
toward the periphery SAN, and a region in the peripheral
SAN tissue close to the superior vena cava became a second-
ary leading pacemaking site. The APs generated by either
site were unable to drive the surrounding atrial muscle, lead-
ing to conduction exit block-a phenomenon typically seen in
the sick sinus syndrome. With an increased ACh concentra-
tion during ischemia, SAN exit block became more likely to
occur than in the control condition with the same level of
ACh (data are not shown).
Detailed analyses were also performed to investigate the
mechanisms by which ischemia affects APs and conduction
in the intact SAN-atrial tissue model and PCL. The results
are shown in Fig. 7. Figure 7(a) plots the measured activation
time for the representative cells across the tissue in control,
ischemia and in ACh with and without ischemia; the corre-
sponding conduction velocity of APs across the tissue was
calculated and shown in Fig. 7(b). Both ischemia and ACh
increased the activation time, but the latter had greater
effects, indicating an increased time required for the AP to
FIG. 5. Dose-dependent effect of ACh on central [left panels, (ai)–(di)] and
peripheral [right panels, (aii)–(dii) SAN cells. (a)–(c), effects of varying
ACh concentrations on APs. (d) Dose-dependence of PCL.
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conduct from SAN to the atrial muscle. In Fig. 7(a), the
sinoatrial-atrium activation time was reduced in the direction
towards the atrium septum in the ischemia and ACh condi-
tion [blue line in Fig. 7(a)]. This was due to the presence of
two leading pacemaking sites in that condition, one of which
was at the peripheral region of the SAN that was close to the
right atrium (i.e., the leading pacemaker site shifted, see Fig.
6(di), snapshot at 40ms), therefore, the time taken to reach
the right atrium was decreased, though the sinoatrial-atrium
conduction was actually slowed down. The increased activa-
tion time in the direction towards the crista terminalis corre-
sponded to a decreased AP conduction velocity as shown in
Fig. 7(b). The increased activation time and the correspond-
ing decreased conduction velocity were attributable to a
decreased upstroke velocity of cellular APs as shown in Fig.
7(c). Ischemia reduced dV/dtmax in both right atrium and
SAN, with a greater effect on the right atrium. Application
of ACh further reduced dV/dtmax in ischemic tissue, most
severely in the SAN peripheral region. A decreased dV/dtmax
in both SAN peripheral regions indicated a reduced driving
power of the SAN and an increased electrical load of the
atrium to the SAN, resulting in an increased PCL and even a
SAN conduction exit block, in which case the SAN failed to
drive the atrial muscle.
IV. DISCUSSION
In this study, we modeled the electrophysiological activi-
ties of central and peripherial SAN cells during ischemia
based on experimental data, and incorporated these models
into an electrophysiologically and anatomically detailed 2D
intact rabbit SAN-atrium model. We investigated the func-
tional role of ischemia-induced alterations at the cellular level
to elucidate which and how these may cause SAN bradycardia
during ischemia, and whether or not these alterations play the
same functional role in both central and peripheral SAN cells.
With the tissue model, we further investigated the functional
effects of SAN ischemia in impairing the ability of the SAN
to pace and drive the surrounding atrial muscle. Our simula-
tion results provide evidence substantiating the causative link
between SAN ischemia and sinus bradycardia. The major
findings of this study are as follows: (1) at the cellular level,
the ischemia-induced bradycardia in both central and periph-
eral cells can be attributed to the intracellular Naþ increase,
IKATP activation, increased ICaL, and the reverse mode of
INaCa; (2) at the intact SAN-atrium tissue level, ischemia
decreased the pacemaking rate and slowed down the AP con-
duction across the SAN-atrium; (3) the bradycardiac effects of
SAN ischemia are likely to be amplified by vagal nerve activ-
ity: simulated addition of ACh to the tissue with ischemia not
only slowed pacemaking and AP conduction, but also com-
promised the ability of the SAN to pace and drive the atrium,
leading to a higher probability of conduction block at the
SAN-atrium junction (a phenomenon known as SAN exit
block); this effect was greater than that seen with ACh alone.
This finding may provide further insight into the mechanism
underlying high risk of cardiac arrest in ischemic patients at
night, when the vagal tone is greater.47,53
FIG. 6. ACh effect on AP initiation and conduction in the 2D intact SAN-atrial tissue. [ACh] ¼ 1.0 106mol/l. (Ai) – (Di) the snapshots of the initiation and
conduction pattern of pacemaking APs in the 2D SAN-atrium. Each snapshot mapped with different colours, which changed from blue for 80mV to red for
40mV. (Aii) – (Dii) The spatial (running vertically) and temporal (running horizontally) profiles of APs (recorded from representative cells along the black
dash line across the SAN-atrium model as shown in figure (Ai) – (Di) for three consecutive cycles.
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A. Ischemia and impaired pacemaking activity
At the cellular level, the main causes of bradycardia
with simulated ischemia are [Naþ]i overload and IKATP acti-
vation in central SAN cells, and an increased ICaL (mainly
prolonged APD, slowing down the repolarization phase)
(Fig. 2, Bi and Fig. S4 in the supplementary material).
Previous experiments on rabbit SAN cells have demonstrated
that the MDP changed and pacemaking rate slowed with the
addition of ATP-sensitive Kþ channel openers.42,43 Our sim-
ulated effect of IKATP is concordant with these experimental
findings. Experimental data have shown that Naþ-Kþ pump
activity was increasingly inhibited during ventricular ische-
mia leading to intracellular Naþ overload.54 We assumed
that a similar intracellular [Naþ]i overload may also occur
during SAN ischemia. The combined effect of the aug-
mented reverse-mode of INaCa and/or INaK, and intracellular
Naþ overload further slowed down pacemaking significantly.
However, in the peripheral cell model the causative link
between SAN ischemia and bradycardia is not exactly the
same as in the central cell model. In the peripheral cell
model, the increased ICaL and intracellular [Na
þ]i are the
major causes of bradycardia, while IKATP activation has little
effect. The rise in intracellular [Naþ]i resulted in functional
changes in ion channel currents (Fig. 3) similar to those in
the central cell. Altogether, our simulation results suggest
that ischemia-induced changes in INaCa and ICaL, and activa-
tion of IKATP play important roles in ischemia-induced brady-
cardia, which could be potential targets for the treatment of
SAN effects of ischemia. Reduction of ICaT had little effect
on AP in our simulation results (Fig. 2) as some prior experi-
mental/modelling studies found.55–57
At the intact SAN-atrium tissue level, ischemia slowed
down the pacemaking rate, as well as the AP conduction
(AP) (Fig. 6). The simulation results of slowed AP conduc-
tion through the SAN-atrium during ischemia are in agree-
ment with experimental observations.58
We simulated the effect of ischemia by considering both
ischemia-induced changes to various ionic currents by alter-
ing their maximum membrane conductances and altered
[Kþ]o and [Na
þ]i. As altered [K
þ]o and [Na
þ]i might pro-
duce a secondary effect on the membrane ion channel cur-
rents of interest, further simulations were conducted to
dissect such a combined process. For this, six different sce-
narios were considered, and the results are shown in the Fig.
S6 (in the supplementary material). The six cases are:
(i) Combined effects of all altered ion channel conduc-
tances (including a decreased conductance of IKr, gKr)
and elevated [K]o and [Na
þ]i [full ischemia condition
considered; results are shown in Figs. S6(ai) and
S6(aii), supplementary material for central and
peripheral cell models, respectively];
(ii) Altered all other ion channel currents with elevated
[K]o and [Na
þ]i, but without reduction in gKr [results
are shown in Figs. S6(bi) and S6(bii), supplementary
material];
FIG. 7. The effect of ACh on AP con-
duction in the normal (Control) tissue
and 2D tissue with SAN ischemia. (A)
Activation times with ischemia and
ACh compared with control condition;
(B) and (C) the relative conduction
velocity and dV/dtmax; (D) PCL in the
2D tissue in the different simulated
conditions, showing augmented effects
when ischemia is combined with ACh
([ACh] ¼ 1.0 106mol/l).
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(iii) Like (i), but with a smaller decrease in gKr [results are
shown in Fig. S6(ci), S6(cii); S6(di), S6(dii), supple-
mentary material].
(iv) Like (i), but without elevated [K]o [results are shown
in Figs. S6(ei) and S6(eii), supplementary material for
central and peripheral cell models respectively];
(v) Like (i), but without elevated [Naþ]i [results are shown
in Figs. S6(fi) and S6(fii), supplementary material];
(vi) Altered ion channel conductances only but without
elevated [K]o and [Na
þ]i [results are shown in Figs.
S6(gi) and S6(gii), supplementary material].
For all cases, the computed reduction in the pacemaking
rate is presented in Figs. S6(hi) and S6(hii), supplementary
material.
As compared to case (i), in the presence of elevated
[Kþ]o, without reducing gKr [Figs. S6(bi) and S6(bii), sup-
plementary material] or with a smaller gKr reduction [Figs.
S6(ci) and S6(cii) and S6(di) and S6(dii), supplementary
material], the simulated results were comparable to the case
(i) (i.e., considering both of all affected ion channels and ele-
vated [Kþ]o). In case (iv), due to un-elevated [K
þ]o, greater
potassium channel currents led to an even greater bradycar-
dia effect [Figs. S6(ei) and S6(eii), supplementary material],
as manifested by a marked increase in the reduction of pace-
making rate [PR; see Figs. S6(hi) and S6(hii), supplementary
material]. Therefore, isolating ischemic effects on ion chan-
nel currents from elevated [Kþ]o do not alter the conclusion
drawn from Fig. 1.
In the absence of an elevated [Naþ]i (with normal [Na
þ]i
¼ 8mM, ENa¼ 76.45mV; with elevated [Naþ]i¼ 13.28mM,
ENa¼ 62.91mV), the PR was increased in the central SAN
cell model but decreased in the periphery SAN cell model
[Figs. S6(fi) and S6(fii), supplementary material]. Further
analysis (Fig. S7, supplementary material) illustrated that
without an elevated [Naþ]i, INaK and the outward mode of
INaCa was reduced [Figs. S7(ci) and S7(di), supplementary
material], resulting in a depolarized MDP and shortened
depolarization phase. Though If was decreased [Fig. S7(bi),
supplementary material], but more depolarized MDP (MDP
 40mV) directly activated ICaL, resulting in faster pace-
making APs as compared to the full ischemic condition. In
the periphery cell model, un-elevated [Naþ]i also decreased
INaK, the outward INaCa and INa [Figs. S7(cii), S7(dii), and
S7(eii), supplementary material], but has little effect on If due
to the negligible change in MDP. Such a combined effect of
these altered four currents slightly increased PR as compared
with the ischemia condition (case i) [Fig. S7(aii), supplemen-
tary material], but still decreased the PR as compared with the
control condition [Fig. S6(hii), supplementary material].
In case (vi), in the absence of elevated [Kþ]o and [Na
þ]i,
a decreased PR in both center and periphery cell models was
observed, which was smaller as compared to that in case (i)
[Figs. S6(hi) and S6(hii), supplementary material].
B. ACh effects on the ischemic SAN
Previous studies have confirmed the negative chrono-
tropic effect of ACh on cardiac pacemaking cells.18–20
However, until now there has been a paucity of information
about effects of ACh on ischemic SAN. The present study
addresses this issue. With increasing ACh concentrations, a
more suppressive effect of ACh on ischemic SAN has been
shown at both cellular and 2-D tissue levels. The augmented
bradycardiac effect of ACh can be attributed to the reduction
of If (Fig. 4), as well as the activation of IK,ACh.
Our simulations demonstrated synergistic effects of ACh
and ischemia: ACh not only further slows down the pacemak-
ing rate in ischemic SAN cells, but also impairs the ability of
the SAN to drive the surrounding atrial muscle, as revealed by
the results shown in Figs. 6 and 7. It was shown that ACh
caused failure of AP conduction from SAN to the atrium in the
ischemic condition, which may contribute to the observed con-
duction failure risks, e.g., atrial fibrillation59 or sinus arrest7
(even sudden death) at night when the vagal tone is high.
C. Limitations
The limitations of the rabbit cell and tissue models used
in our study have been described previously.30,31 In order to
produce ischemic SAN cell models, we modified the equa-
tions for ICaL, ICaT, IKr, IKs, INaCa, and If based on available
experimental data from rabbit SAN cells.6,16,17 Other
changes incorporated into our models came from mamma-
lian ventricular ischemia experiments.14,37,38,45,49,50 The
IKATP formulation here was based on that from a guinea pig
ventricular cell model.45 In cases where data from a specific
species/cell type are unavailable, it is accepted practice to
use data from other species or cell-types in cardiac modeling.
In this regard, it is notable that our simulation results of
ischemia-induced bradycardia at the single-cell level showed
good agreement with experimental data from ischemic rabbit
SAN cells,6,16 suggesting that the parameters in our ischemic
models are reasonable. Although our 2D anatomical tissue
model considered the intrinsic electrical heterogeneity of
SAN-atrial tissue, further 3-D anatomical models may be
required to investigate fully AP initiation in the SAN and con-
duction from SAN toward atrium (e.g., to establish precise
locations of the sinus exit block sites with different concentra-
tions of ACh and/or with different extents of SAN ischemia),
which may depend on the details of the tissue spatial struc-
ture, 3D heterogeneity and anisotropy. Nevertheless, although
the dimensions of our tissue model have been reduced from
full 3-D to 2-D, the results of our simulations provide valu-
able insights into mechanistic links between SAN ischemia
and ischemia-induced sinus bradycardia. Moreover, gap junc-
tion uncoupling may happen during SAN ischemia as reported
in ventricular ischemia,60 which warrants further study by
using bi-domain models to capture gap junction remodeling
during ischemic conditions.
SUPPLEMENTARY MATERIAL
See supplementary material for the model equations,
parameters and additional results.
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